Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Broker Upgrades Boost Tesco And GKN

Fri, 08th Jan 2016 10:25

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.
----------
FTSE 100 - WINNERS
----------
Tesco, up 5.2%. The supermarket was boosted by Barclays upgrading its rating on the group to Overweight from Equal Weight, though it cut its target price to 190 pence from 225p. Tesco shares were trading at 146.5p. Barclays said the recent underperformance in Tesco's share price has left its valuation looking attractive, despite the numerous challenges facing the UK's food retail market. It also reckons Tesco's upcoming trading statement, due next week, will be "less worrisome" than markets anticipate.

GKN, up 5.0%. The aerospace and automotive engineer received a double upgrade from Bank of America Merrill Lynch, which hiked its rating on the company to Buy from Underperform.
----------
FTSE 100 - LOSERS
----------
Intu Properties, down 0.5%. The UK shopping centre owner was downgraded to Sell from Hold by Societe Generale as part of a wide-ranging note by the French bank on whether the bull run for the UK property sector has reached a tipping point. SocGen said that while valuations may look attractive at first glance in the UK property sector, it thinks the cyclical downturn in the market will start this year and carry though to 2018, by which point returns in the sector will turn negative. Intu also was hit by a downgrade by Exane BNP Paribas, which cut its rating on the stock to Underperform from Neutral.
----------
FTSE 250 - WINNERS
----------
Vectura Group, up 5.3%. The pharmaceutical company said it has completed a clinical trial for VR315 in the US, its generic therapy for asthma, and provided an update on one of its other developments. On VR506, another asthma treatment programme the company is working on in the US, Vectura has received an initial payment of USD4.0 million and a further USD8.0 million could be received once further development milestones are hit, and the company will also receive a royalty once sales start.

B&M European Value Retail, up 5.1%. The discount retailer was boosted by a note from Investec, which said the recent weakness in its share price presented a buying opportunity for shareholders. Though slowing like-for-like sales for B&M and the likelihood its Christmas will have proven difficult does not help its case, Investec said sentiment should start to improve in the 2017 financial year through a recovery in like-for-like sales growth, an update on its roll-out in Germany, and confirmation of the appropriate capital structure of the group, given B&M's strong cash generation record and the potential for capital returns.
----------
FTSE 250 - LOSERS
----------
PayPoint, down 0.8%. The payments company said it has agreed to sell its online payment businesses, comprising of PayPoint.net and Metacharge, to FTSE 100-listed outsourcer Capita for GBP14 million. "In line with our strategy, we are pleased to have agreed the sale of our Online Payment businesses. We announced our intention to sell our Mobile and Online businesses at our full year results last May, in order to focus on multi-channel payments where we have retail networks, to concentrate on our best prospects for future growth," said Chief Executive Dominic Taylor in a statement.
----------
MAIN MARKET AND AIM - WINNERS
----------
REACT Energy, up 23%. The company said it has secured a EUR750,000 loan facility to continue its development of biomass gasification projects in the UK, awarding the loan provider's subsidiary a contract in return. The EUR750,000 unsecured facility is being provided by EBIOSS Energy AD, and whilst not formally part of the deal, REACT has awarded exclusivity to one of EBIOSS' subsidiaries to supply gasification technology as part of any engineering, procurement and construction contracts for its UK projects.

Sopheon, up 17%. The software provider said its full-year earnings will be ahead of current market expectations as the positive shift in momentum of the business continued in the second half of the year. Sopheon said full-year revenue was set to "comfortably" hit expectations whilst pretax profit and earnings before interest, tax, depreciation and amortisation are set to come in higher than forecast. The news confirms the company's outlook reported back in August, when it said it was on the "right path" moving forward despite reporting a fall in revenue as a result of fewer licence orders in the first half of 2015.
----------
MAIN MARKET AND AIM - LOSERS
----------
Games Workshop Group, down 11%. The company, which makes Warhammer miniatures, said its pretax profit came in flat for the first half but said trading over the Christmas period missed its expectations, leading it to caution profit for the full year is likely to fall. The company said its sales in December were lower across the business and, as a result, pretax profit for the full year is unlikely to exceed GBP16.0 million, compared to the GBP16.6 million it posted a year earlier. For the first half to November 29, Games Workship said its pretax profit was flat at GBP6.3 million, as revenue dipped slightly to GBP55.3 million from GBP56.5 million. Due to the sluggish first half and its caution on the second, the company slashed its interim dividend to 20.00 pence per share from 36.00p a year earlier.
----------
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
26 May 2021 11:32

LIVE MARKETS-U.S. stock valuations face headwinds

* European shares erase gains* Fed soothes inflation fears* U.S. equity futures edge upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thoms...

Read more
26 May 2021 11:15

TOP NEWS: Carlyle offers GBP958 million for asthma drug maker Vectura

TOP NEWS: Carlyle offers GBP958 million for asthma drug maker Vectura

Read more
26 May 2021 11:06

LIVE MARKETS-Equities: another choppy summer?

* European shares up 0.1%* Fed soothes inflation fears* U.S. equity futures upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters...

Read more
26 May 2021 10:04

LIVE MARKETS-Who is paying dividends

* European shares up 0.2%* Fed soothes inflation fears* U.S. equity futures edge upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonre...

Read more
26 May 2021 09:33

LIVE MARKETS-M&S: a tricky morning call

* European shares up 0.2%* Fed soothes inflation fears* U.S. equity futures edge upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonre...

Read more
26 May 2021 09:18

UPDATE 2- British midcaps rise on strong earnings, Vectura shines

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Vectura surges on agreeing to $1.4 bln takeover by Carlyle* Marks & Spencer rises on positive profit outlook* Croda rises on double upgrade...

Read more
26 May 2021 08:47

LONDON MARKET OPEN: Vectura and Mediclinic boost FTSE 250 amid M&A

LONDON MARKET OPEN: Vectura and Mediclinic boost FTSE 250 amid M&A

Read more
26 May 2021 08:44

LIVE MARKETS-STOXX below peak, banks dip, some M&A action

* European shares up 0.2%* Fed soothes inflation fears* U.S. equity futures edge upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonre...

Read more
26 May 2021 08:44

LIVE MARKETS-STOXX below peak, banks dip, some M&A action

* European shares up 0.2%* Fed soothes inflation fears* U.S. equity futures edge upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonre...

Read more
26 May 2021 07:57

LONDON MARKET PRE-OPEN: Vectura and Spire Healthcare accept offers

LONDON MARKET PRE-OPEN: Vectura and Spire Healthcare accept offers

Read more
26 May 2021 07:56

Vectura to be taken over by Carlyle in £958m deal

(Sharecast News) - Pharmaceutical company Vectura said on Wednesday that it has agreed to be taken over by US private equity firm The Carlyle Group in a £958m deal, sending the shares sharply higher.

Read more
26 May 2021 07:38

UPDATE 1-UK pharma group Vectura agrees $1.4 bln takeover by Carlyle

(Adds details)LONDON, May 26 (Reuters) - Vectura Group, a British pharmaceutical company focused on inhaled medicines, said on Wednesday it had agreed a 958 million pound ($1.36 billion) takeover by global investment firm The Carlyle Group.Shareho...

Read more
26 May 2021 07:12

Vectura agrees 958 mln stg takeover by The Carlyle Group

LONDON, May 26 (Reuters) - Vectura Group, a British pharmaceutical company focused on inhaled medicines, said on Wednesday it had agreed a 958 million pound ($1.36 billion) takeover by global investment firm The Carlyle Group. ($1 = 0.7067 pounds...

Read more
20 May 2021 16:07

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
21 Apr 2021 10:06

Hikma resumes asthma drug launch, Vectura pays special dividend

Hikma resumes asthma drug launch, Vectura pays special dividend

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.